BioCryst Pharmaceuticals (BCRX) Stock Price & Financial Analysis
BioCryst Pharmaceuticals Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About BioCryst Pharmaceuticals
What is the current stock price for BCRX?
As of the latest trading session, BCRX stock trades at $9.02. The 52-week range is $6.00–$11.31, with a day range of $8.92–$9.35.
What is the P/E ratio for BCRX?
BioCryst Pharmaceuticals's trailing P/E ratio is 7.8, meaning investors pay $7.8 for every $1 of annual earnings. BioCryst Pharmaceuticals operates in the Healthcare sector.
Does BCRX pay dividends?
BioCryst Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for BCRX?
Based on 6 analysts, the consensus for BCRX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of BCRX?
BioCryst Pharmaceuticals's market capitalization is $1.98B, classifying it as a small-cap company. BioCryst Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.